Neochem Bio SME
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Grey market premium
Unofficial and indicative — not a forecast
3 observations recorded — too few to plot a trend.
Day-wise premium · 3 observations
| Date | GMP | % | Sauda | Est. listing | Gain / lot |
|---|---|---|---|---|---|
| 08 Dec 2025 | ₹2 | +2.04% | ₹1,800 | ₹100 | ₹2,400 |
| 07 Dec 2025 | ₹10 | +10.20% | ₹9,100 | ₹108 | ₹12,000 |
| 06 Dec 2025 | ₹10 | +10.20% | ₹9,100 | ₹108 | ₹12,000 |
Gain per lot assumes the premium holds to listing and that the application is allotted — allotment in an oversubscribed issue is a lottery, so it is indicative, not expected. Sauda is the rate paid for a submitted application itself.
Issue details
- Listing date
- 09 Dec 2025
- Face value
- ₹10 per share
- Issue price
- ₹98 per share
- Lot size
- 1,200 shares
- Total issue size
- ₹44.97 Cr
- Market cap at offer price
- ₹168 Cr
- Promoter holding
- 91.12% → 66.70% pre-issue → post-issue
- ISIN
- INE21UM01018
- Registrar
- MUFG Intime India Pvt.Ltd.
- Lead managers
- Vivro Financial Services Pvt.Ltd.
- Registered office
- 303, W1, Opp.Vikramnagar Colony, Off.Iscon-Ambli Road, Gujarat
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| Anchor investor · within QIB | 13,03,200 | — | — |
| Market maker | 2,32,800 | — | — |
Application size
Minimum 1,200 shares per lot, in multiples, at ₹98
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 1,200 | ₹1,17,600 |
| S-HNI (min) | 2 | 2,400 | ₹2,35,200 |
| S-HNI (max) | 8 | 9,600 | ₹9,40,800 |
| B-HNI (min) | 9 | 10,800 | ₹10,58,400 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Anchor investors
Institutional allocation placed a day before the issue opens, carved out of the QIB portion and locked in after listing.
Valuation and performance
Valuation at offer price
₹98 per share
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 6.18 | 6.41 |
| P/E (×) | 15.86 | 15.29 |
| Price to book (×) | 5.80 | — |
| Market cap | — | ₹168 Cr |
Key performance indicators
Latest reported period
- Return on net worth
- 48.82%
- ROCE
- 41.67%
- Debt / equity
- 1.80
- PAT margin
- 9.00%
- EBITDA margin
- 15.58%
- NAV per share
- ₹16.91
- Price to book
- 5.80
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.
About Neochem Bio SME
Neochem Bio Solutions Limited (formerly Neochem Technologies Private Limited) was originally formed as a partnership firm in 1978 and converted to a private limited company in 2017. The company is engaged in manufacturing specialty performance chemicals with a diverse portfolio of over 350 customized formulations across four primary product segments: Polymers, Surfactants, Silicones, and Esters & bio-based sustainable solutions. The company's products are essential materials used by manufacturers in textiles & garment washing, home & personal care, institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber, and dyes and pigments. The company is accredited with ISO 9001:2015, ISO 14001 and ISO 45001, with product certifications including ZDHC Level 3 and GOTS 7.0. For FY 2024-25, the company generated revenue from operations of ₹8,417.27 lakhs with a profit after tax of ₹775.07 lakhs.
Company Analysis
from RHPNeochem Bio Solutions Limited is a specialty performance chemicals manufacturer with over 40 years of heritage, serving textile, home & personal care, industrial cleaning, water treatment, paints, coatings, paper, pulp, construction, rubber, and dye & pigment industries across four primary product segments.
Neochem Bio Solutions Limited (formerly Neochem Technologies Private Limited) was originally formed as a partnership firm in 1978 and converted to a private limited company in 2017. The company is engaged in manufacturing specialty performance chemicals with a diverse portfolio of over 350 customized formulations across four primary product segments: Polymers, Surfactants, Silicones, and Esters & bio-based sustainable solutions. The company's products are essential materials used by manufacturers in textiles & garment washing, home & personal care, institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber, and dyes and pigments. The company is accredited with ISO 9001:2015, ISO 14001 and ISO 45001, with product certifications including ZDHC Level 3 and GOTS 7.0. For FY 2024-25, the company generated revenue from operations of ₹8,417.27 lakhs with a profit after tax of ₹775.07 lakhs.
Objects of the Issue
- Funding the long-term working capital requirements of the Company ₹2,390.00 lakhs p.28
- Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company ₹1,000.00 lakhs p.28
- General Corporate Purposes p.28
- Funding long-term working capital requirements of the Company p.53
- Repayment of borrowings p.65
- General Corporate Purposes p.65
- Funding the long-term working capital requirements of the Company ₹2,390.00 lakhs (FY2026: ₹990.00 lakhs; FY2027: ₹1,400.00 lakhs) p.113
- Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company ₹1,000.00 lakhs (FY2026: ₹1,000.00 lakhs; FY2027: ₹0) p.113
- General Corporate Purposes Not to exceed 15% of Gross Proceeds or ₹1,000.00 lakhs, whichever is lower p.113
- Repayment of borrowings p.110
- Issue Expenses p.334
Issue Structure
- Total Issue
- Up to 45,88,800 Equity Shares of face value of ₹10/- each aggregating to ₹ [●] lakhs
- Fresh Issue
- Up to 45,88,800 Equity Shares of face value of ₹10/- each aggregating to ₹ [●] lakhs
- Offer for Sale
- NIL
- Price Band
- [●] (Floor Price to Cap Price, to be decided by the company in consultation with the Book Running Lead Manager)
- Lot Size
- [●] (Minimum Bid Lot to be decided)
- Face Value
- ₹10/- per equity share
Business Model
The company manufactures and sells specialty performance chemical formulations to diverse customers through a business-to-business model. Revenue is generated through sales of customized chemical products to textile manufacturers, home & personal care manufacturers, industrial cleaning companies, water treatment facilities, paint and coating producers, paper and pulp manufacturers, construction companies, rubber manufacturers, and dye & pigment companies. The company operates through its sole manufacturing facility in Moraiya, Ahmedabad with an installed capacity of 22,000 MTPA and distributes through a network of over 50 distributors across India. For FY 2024-25, cost of materials consumed represented 66.02% of revenue from operations.
Business Segments
SWOT Analysis
- • Diverse product portfolio across four primary segments with 350+ formulations and strong certifications(p.27)
- • Legacy of over four decades in specialty chemicals manufacturing(p.27)
- • Pan-India distribution network with 50+ distributors as of September 2025(p.43)
- • Strong financial performance with growing profitability and return metrics(p.30)
- • Significant revenue and profit growth trajectory(p.60)
- • Commitment to sustainable and eco-friendly product development(p.53)
- • Diversified customer base across geographies and industries(p.57)
- • Differentiated product strategy through customization and sustainability(p.57)
- • Established long-standing relationships with customers across end-use industries(p.126)
- • Integrated and flexible manufacturing operations for sustainable formulations enabling customized supply(p.126)
- • Strong understanding of applied chemistries for diverse end-use industries(p.126)
- • Research and development capabilities for development of innovative performance chemistries(p.126)
- • Established sales and distribution network(p.126)
- • Experienced Promoters with strong management team having domain knowledge(p.126)
- • Strong revenue growth from ₹4,818.84 lakhs in Fiscal 2023 to ₹8,417.27 lakhs in Fiscal 2025 (37.66% growth in FY25)(p.117)
- • Improved profitability with PAT margin increasing from 2.20% in FY23 to 9.00% in FY25(p.128)
- • Integrated manufacturing enabling customized formulations at scale(p.180)
- • Strong application knowledge across diverse end-use industries(p.180)
- • Portfolio of 350+ customized formulations with proprietary brands(p.180)
- • Established pan-India distribution network with 50+ distributors(p.183)
- • In-house R&D capabilities for sustainable product development(p.183)
- • Zero-liquid discharge facility with international certifications(p.185)
- • Experienced management team with 20+ years in specialty chemicals(p.184)
- • Diversified portfolio of 350+ customized formulations across four product segments(p.292)
- • Recognized process and product certifications (ISO 9001:2015, ISO 14001, ISO 45001, ZDHC Level 3, GOTS 7.0)(p.292)
- • Comprehensive product range serving multiple industries (textile, HPC, water treatment, paints, paper, construction, rubber, dyes)(p.292)
- • Legacy of over four decades in specialty chemicals manufacturing(p.292)
- • Strong revenue growth and capacity utilization improvement(p.296)
- • Expanding customer base supporting revenue growth(p.298)
- • Significant profitability improvement with PAT growth(p.297)
- • Improved operational efficiency with lower other expenses as percentage of income(p.297)
- • Moderate employee benefit expenses as percentage of income declining(p.297)
- • Intellectual property portfolio with 40 registered trademarks(p.317)
- • High dependence on textile industry revenues (77% in H1 FY26, 95.92% in FY23)(p.37)
- • Significant revenue concentration from top customers (43.47% from top 5 customers in H1 FY26)(p.37)
- • Low capacity utilization at 22.74% as of September 30, 2025(p.38)
- • Heavy dependence on Gujarat suppliers (51.04% of purchases in H1 FY26)(p.53)
- • Geographic concentration with 94.31% of domestic revenue in H1 FY26(p.39)
- • Limited long-term contractual arrangements with customers and suppliers(p.38)
- • Significant reliance on a single manufacturing facility in Moraiya, Ahmedabad(p.41)
- • Negative cash flow from operating activities in H1 FY26 (₹768.92 lakhs deficit)(p.47)
- • High raw material cost dependence (65.79% of revenue in H1 FY26)(p.40)
- • High revenue dependence on repeat customers (99.05% in H1 FY26)(p.53)
- • Revenue concentration from Gujarat region (55.08% in H1 FY26)(p.51)
- • Regulatory compliance delays and filing issues under Companies Act, 2013(p.43)
- • High concentration of revenue in top customers(p.57)
- • Significant working capital requirements and reliance on credit facilities(p.54)
- • Increasing trade receivables and collection period extending(p.55)
- • Promoter dependency and personal guarantees backing loans(p.60)
- • Delays in statutory compliance and tax payments(p.55)
- • High debt-to-equity ratio of 1.80 in FY25, though improving from 3.26 in FY23(p.128)
- • Relatively low current ratio of 1.21 in FY25, indicating modest short-term liquidity position(p.128)
- • Company has 14 shareholders with highly concentrated promoter ownership at 91.12% of pre-issue capital(p.104)
- • Low capacity utilization of 41.82% as of March 31, 2025 and 22.74% as of September 30, 2025(p.118)
- • Significant increase in working capital requirement as percentage of revenue from 28.65% in FY23 to 34.41% in FY25(p.117)
- • High revenue concentration in textile industry at 77%(p.184)
- • Low capacity utilization at 41.82% in FY2025(p.197)
- • Significant customer concentration with top customer at 24.28% of revenue(p.182)
- • High supplier concentration with top supplier at 16.52% of purchases(p.194)
- • Dependence on imported raw materials (2.65% of purchases)(p.195)
- • Leased warehouse and office facilities expiring soon(p.204)
- • High debt-to-equity ratio; significant reliance on debt financing(p.291)
- • Outstanding litigation with insolvent customer (Morarjee Textile Limited); ₹27.97 lakhs receivable pending NCLT resolution(p.257)
- • Concentration of promoter shareholding; two promoters hold 83.16% of pre-issue capital(p.229)
- • Material receivables pending from one related-party customer (D R Enterprise); ₹2,249.88 lakhs outstanding(p.287)
- • High dependence on top five customers(p.304)
- • Significant outstanding borrowings and finance costs(p.295)
- • High cost of materials as primary expense component(p.294)
- • Negative operating cash flow in recent half-year(p.302)
- • High trade payables and working capital requirements(p.301)
- • Growing Indian specialty chemicals market projected to reach Rs 7.5 lakh crore by FY29 at 10-12% CAGR(p.27)
- • Global chemicals industry growing at 7% CAGR projected to reach $8.3 trillion by 2029(p.27)
- • Scope for expanding export presence beyond current 12 countries with only 5.7% export contribution(p.51)
- • Potential to expand international customer base with current limited export penetration(p.39)
- • Capacity expansion opportunity given only 22.74% utilization at 22,000 MT installed capacity(p.38)
- • Opportunity to develop eco-friendly and sustainable specialty chemicals as emphasized(p.37)
- • Rapid growth in global specialty chemicals market(p.58)
- • Expansion into international markets as strategic growth initiative(p.60)
- • Growth through strengthening presence across end-user application industries(p.60)
- • Transition toward green chemistry and sustainability-driven market demand(p.58)
- • India's bio-industrial sector growing at ~8% CAGR with market expected to reach Rs 10.4 lakh crore by 2030(p.144)
- • Expansion of geographies reach, diversification across end-use application industries and optimizing production capacities(p.114)
- • Domestic specialty chemicals market projected to grow from Rs 5.0 lakh crore in FY25E to Rs 7.5 lakh crore by FY29P at 10-12% CAGR(p.151)
- • Global specialty chemicals market expected to grow at 8% CAGR from 2024-2029, reaching $1,748 billion(p.147)
- • India specialty chemicals projected to record highest growth rate of 10-12% from 2025-2029 among key Asian economies(p.150)
- • Rising global and domestic demand to lift capex plans in specialty chemical sector with over ₹16,100 crores investment in next three years(p.154)
- • China+1 strategy positioning India as preferred destination for sourcing specialty chemicals(p.151)
- • Indian home and personal care market projected at 10-12% CAGR(p.184)
- • Strategic opportunity to diversify beyond textile into growth segments(p.184)
- • Global home and personal care chemicals market expanding at 6.35% CAGR(p.184)
- • Growing demand for sustainable and bio-based formulations(p.185)
- • Expansion into 12 international markets with growth potential(p.186)
- • Strategic distribution partnerships to enter new geographies(p.188)
- • Rising demand for home and personal care products(p.293)
- • Growth potential in bio-based sustainable solutions segment(p.292)
- • Export market expansion; current export sales of ₹261.30 lakhs in H1 FY26(p.281)
- • Capacity utilization improvement opportunity; company has manufacturing facilities at multiple locations(p.293)
- • Increasing capacity utilization with additional growth potential(p.296)
- • Subsidy income growth from government support schemes(p.296)
- • Export benefits income expansion(p.296)
- • Growing customer base continues to expand(p.298)
- • Inherent cyclicality and downturn risks in textile industry affecting demand(p.37)
- • Intense competition and price pressures from domestic and international manufacturers(p.51)
- • Fragmentation and commoditization of textile chemical market creating pricing pressures(p.37)
- • Volatile raw material prices and supply disruption risks from crude and chemical derivatives(p.40)
- • Dependence on continuous supply of water and electricity for manufacturing operations(p.41)
- • Exposure to industrial accident and hazard risks inherent in chemical manufacturing(p.42)
- • Risk of regulatory changes and compliance requirements affecting operations and costs(p.44)
- • Potential revocation or suspension of statutory licenses and regulatory approvals(p.44)
- • Seasonal and cyclical volatility in textile demand affecting sales volumes and inventory(p.53)
- • Vulnerability to adverse developments in Gujarat affecting operations and sourcing(p.53)
- • External market risks including recession, inflation and foreign exchange volatility(p.25)
- • GST litigation and regulatory proceeding involving demand of ₹7.34 lakhs(p.46)
- • Highly competitive specialty chemicals industry with established global players(p.58)
- • Business vulnerable to seasonal demand fluctuations and inventory risk(p.54)
- • Dependence on imported raw materials and foreign exchange exposure(p.57)
- • Vulnerability to currency exchange rate fluctuations(p.59)
- • Competitive pressures on direct and indirect customers impacting demand(p.57)
- • Supply chain disruptions and transportation risks(p.59)
- • Geopolitical risks and trade policy uncertainties(p.76)
- • Funding requirements and deployment of Net Proceeds based on management estimates without external appraisal(p.113)
- • Variation in funding requirements may be necessitated by external factors beyond management control(p.113)
- • Global economic growth slowing from 3.5% in CY23 to projected 2.8% for CY25(p.138)
- • Global trade disruption from prolonged geopolitical tensions and new US tariffs impacting economic growth(p.138)
- • Risk of shortfall in Net Proceeds affecting deployment schedule(p.114)
- • Volatile raw material costs and price competitiveness pressures(p.173)
- • Supply chain vulnerability and import dependence(p.173)
- • Stringent regulatory and environmental compliance requirements(p.173)
- • Intense competitive pressure from domestic and international players(p.174)
- • Cyclicality of end-use markets affecting demand patterns(p.174)
- • High R&D costs and extended product development timelines(p.174)
- • Significant fluctuation in raw material costs and forex rates affecting profitability(p.293)
- • High competition and market fragmentation in specialty chemicals(p.293)
- • Limited awareness and slower adoption of bio-based chemical alternatives in some sectors(p.293)
- • Disruption risks to supply chain and labor availability at manufacturing facilities(p.293)
- • Government regulations and policies affecting operations(p.293)
- • Interest rate risk from variable rate borrowings(p.303)
- • Credit risk from counterparties and customer default(p.303)
- • Liquidity risk associated with operations(p.303)
- • Pending GST tax demand affecting operations(p.310)
Promoters
| Name | Role | Pre-Issue | Post-Issue |
|---|---|---|---|
| Swapnil Rameshbhai Makati | Promoter | 74.54% | — |
| Hemangini Swapnil Dathia | Promoter | 8.62% | — |
| Swapnil Rameshbhai Makati | Promoter | — | — |
| Hemangini Swapnil Dathia | Promoter | — | — |
| Swapnil Rameshbhai Makati | Promoter | 74.54% | — |
| Hemangini Swapnil Dathia | Promoter | 8.62% | — |
| Meenaben Rameshbhai Dathia | Promoter Group | 7.95% | — |
| Swapnil Rameshbhai Makati | Promoter and Managing Director | — | — |
| Hemangini Swapnil Dathia | Promoter and Director | — | — |
| Swapnil Rameshbhai Makati | Promoter | 74.54% | — |
| Hemangini Swapnil Dathia | Promoter | 8.62% | — |
| Swapnil Rameshbhai Makati | Promoter | — | — |
| Hemangini Swapnil Dathia | Promoter | — | — |
Leadership
Auto-extracted from the company's RHP using AI, with each fact linked to its source passage (hover any row to see the quote & page). Provided for research only, not investment advice — verify against the official RHP before relying on it.